Literature DB >> 10360477

Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents.

M Kurimoto1, S Endo, Y Hirashima, H Hamada, T Ogiichi, A Takaku.   

Abstract

The authors examined the effect of nitric oxide (NO) generating agents on the growth and radiosensitivity of cultured glioma cells. Three glioma, rat C6, and human T98G and U87 cell lines were treated with the NO generating agents, S-nitroso-N-acetyl-penicillamine (SNAP) or sodium nitroprusside (SNP). These agents released NO in the cell culture media and inhibited the growth of the glioma cells. Growth-inhibition was attenuated by hemoglobin, a known inhibitor of NO, suggesting it is mediated by NO. When C6 and T98G cells were irradiated in the presence of SNAP or SNP at 100 microM, radiosensitization was observed. SNAP at 100 microM exhibited a sensitizer enhancement ratio (SER) of 1.4 for C6 cells and 1.8 for T98G cells. SNP at 100 microM only radiosensitized T98G cells with a SER of 1.9. The effect of SNP on radiosensitization of C6 cells was unclear. We conclude that NO generating agents are potential growth inhibitors and radiosensitizers for malignant glioma cells. NO mediated radiosensitization of glioma cells by NO generating agents may offer a new therapeutic approach for malignant glioma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360477     DOI: 10.1023/a:1006160305294

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  38 in total

Review 1.  Nitric oxide and synaptic function.

Authors:  E M Schuman; D V Madison
Journal:  Annu Rev Neurosci       Date:  1994       Impact factor: 12.449

2.  Radiosensitization of hypoxic tumor cells in vitro by nitric oxide.

Authors:  R J Griffin; C M Makepeace; W J Hur; C W Song
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-09-01       Impact factor: 7.038

3.  Radiation sensitisation by nitric oxide releasing agents.

Authors:  J B Mitchell; J A Cook; M C Krishna; W DeGraff; J Gamson; J Fisher; D Christodoulou; D A Wink
Journal:  Br J Cancer Suppl       Date:  1996-07

4.  Role of nitric oxide synthase-containing vascular nerves in cerebrovasodilation elicited from cerebellum.

Authors:  C Iadecola; F Zhang; X Xu
Journal:  Am J Physiol       Date:  1993-04

5.  Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro.

Authors:  B Mitrovic; L J Ignarro; S Montestruque; A Smoll; J E Merrill
Journal:  Neuroscience       Date:  1994-08       Impact factor: 3.590

6.  Nitric oxide synthase activity in human gynecological cancer.

Authors:  L L Thomsen; F G Lawton; R G Knowles; J E Beesley; V Riveros-Moreno; S Moncada
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

7.  Enhanced release of nitric oxide causes increased cytotoxicity of S-nitroso-N-acetyl-DL-penicillamine and sodium nitroprusside under hypoxic conditions.

Authors:  I Ioannidis; M Bätz; T Paul; H G Korth; R Sustmann; H De Groot
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

8.  Improved bioassay for the detection of transforming growth factor-beta 1 and beta 2 in malignant gliomas.

Authors:  H Naganuma; A Sasaki; E Satoh; T Sakihama; K Tasaka; H Nukui
Journal:  Neurol Med Chir (Tokyo)       Date:  1994-03       Impact factor: 1.742

Review 9.  Nitric oxide: mediator, murderer, and medicine.

Authors:  E Anggård
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

10.  Nitric oxide synthase activity in human breast cancer.

Authors:  L L Thomsen; D W Miles; L Happerfield; L G Bobrow; R G Knowles; S Moncada
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  7 in total

1.  Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.

Authors:  Anh Nhat Tran; Kiera Walker; David G Harrison; Wei Chen; James Mobley; Lauren Hocevar; James R Hackney; Randee S Sedaka; Jennifer S Pollock; Matthew S Goldberg; Dolores Hambardzumyan; Sara J Cooper; Yancey Gillespie; Anita B Hjelmeland
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

Review 2.  NOS Expression and NO Function in Glioma and Implications for Patient Therapies.

Authors:  Anh N Tran; Nathaniel H Boyd; Kiera Walker; Anita B Hjelmeland
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

Review 3.  Pharmacotherapy of malignant astrocytomas of children and adults: current strategies and future trends.

Authors:  M T Jennings; S Iyengar
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Effects of Lonomia obliqua caterpillar venom upon the proliferation and viability of cell lines.

Authors:  Tiago Elias Heinen; Caroline Brunetto de Farias; Ana Lucia Abujamra; Ronaldo Zucatelli Mendonça; Rafael Roesler; Ana Beatriz Gorini da Veiga
Journal:  Cytotechnology       Date:  2013-01-22       Impact factor: 2.058

5.  Effects of ERK1/2 S-nitrosylation on ERK1/2 phosphorylation and cell survival in glioma cells.

Authors:  Lei Jin; Yujia Cao; Tong Zhang; Peng Wang; Daofei Ji; Xuejiao Liu; Hengliang Shi; Lei Hua; Rutong Yu; Shangfeng Gao
Journal:  Int J Mol Med       Date:  2017-12-20       Impact factor: 4.101

6.  NO-Donor Iron Nitrosyl Complex with N-Ethylthiourea Ligand Exhibits Selective Toxicity to Glioma A172 Cells.

Authors:  Nataliya Sanina; Natal'ya Shmatko; Tatiyana Stupina; Anastasiya Balakina; Alexei Terent'ev
Journal:  Molecules       Date:  2017-08-29       Impact factor: 4.411

7.  Involvement of NOS2 Activity on Human Glioma Cell Growth, Clonogenic Potential, and Neurosphere Generation.

Authors:  Paola Palumbo; Francesca Lombardi; Giuseppe Siragusa; Soheila Raysi Dehcordi; Sabino Luzzi; AnnaMaria Cimini; Maria Grazia Cifone; Benedetta Cinque
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.